More than 90% of patients with JMML harbor mutually exclusive somatic and/or germline mutations in canonical RAS pathway genes, including PTPN11, NF1, NRAS, KRAS, and CBL6. The gene discussed is NF1; the disease is juvenile myelomonocytic leukemia.